Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa

Francisco Álvarez Lerma; Rosana Muñoz Bermudez; Santiago Grau; María Pilar Gracia Arnillas; Luisa Sorli; Lluis Recasens; Miquel Mico García

Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa

Francisco Álvarez Lerma, Rosana Muñoz Bermudez, Santiago Grau, María Pilar Gracia Arnillas, Luisa Sorli, Lluis Recasens, Miquel Mico García

Research output: Contribution to journal › Article › Research › peer-review

6 Citations (Scopus)

Abstract

© 2017, Sociedad Espanola de Quiminoterapia. All rights reserved. The use of colistin for the treatment of multiresistant bacteria has led to the emergence of colistin-resistant strains of Gram-negative bacilli. Treatment of infections caused by these pan–drug-resistant bacteria is difficult owing to the paucity of effective antibiotics. We report two cases of ventilator-associated respiratory infection caused by pan–drug-resistant, colistin-resistant Pseudomonas aeruginosa that were successfully treated with ceftolozane-tazobactam.

Original language	English
Pages (from-to)	224-228
Journal	Revista Espanola de Quimioterapia
Volume	30
Issue number	3
Publication status	Published - 1 Jun 2017

Keywords

Ceftolozane-tazobactam
Colistin-resistant pseudomonas aeruginosa
ICU
Ventilator-associated respiratory infection

Fingerprint Dive into the research topics of 'Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa'. Together they form a unique fingerprint.

Cite this

@article{04630cf5af2a4bb0871db384b09d21ac,

title = "Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa",

abstract = "{\textcopyright} 2017, Sociedad Espanola de Quiminoterapia. All rights reserved. The use of colistin for the treatment of multiresistant bacteria has led to the emergence of colistin-resistant strains of Gram-negative bacilli. Treatment of infections caused by these pan–drug-resistant bacteria is difficult owing to the paucity of effective antibiotics. We report two cases of ventilator-associated respiratory infection caused by pan–drug-resistant, colistin-resistant Pseudomonas aeruginosa that were successfully treated with ceftolozane-tazobactam.",

keywords = "Ceftolozane-tazobactam, Colistin-resistant pseudomonas aeruginosa, ICU, Ventilator-associated respiratory infection",

author = "Lerma, {Francisco {\'A}lvarez} and Bermudez, {Rosana Mu{\~n}oz} and Santiago Grau and Arnillas, {Mar{\'i}a Pilar Gracia} and Luisa Sorli and Lluis Recasens and Garc{\'i}a, {Miquel Mico}",

year = "2017",

month = jun,

day = "1",

language = "English",

volume = "30",

pages = "224--228",

journal = "Revista Espanola de Quimioterapia",

issn = "0214-3429",

publisher = "Sociedad Espanola de Quiminoterapia",

number = "3",

}

Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa. / Lerma, Francisco Álvarez; Bermudez, Rosana Muñoz; Grau, Santiago; Arnillas, María Pilar Gracia; Sorli, Luisa; Recasens, Lluis; García, Miquel Mico.

In: Revista Espanola de Quimioterapia, Vol. 30, No. 3, 01.06.2017, p. 224-228.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa

AU - Lerma, Francisco Álvarez

AU - Bermudez, Rosana Muñoz

AU - Grau, Santiago

AU - Arnillas, María Pilar Gracia

AU - Sorli, Luisa

AU - Recasens, Lluis

AU - García, Miquel Mico

PY - 2017/6/1

Y1 - 2017/6/1

N2 - © 2017, Sociedad Espanola de Quiminoterapia. All rights reserved. The use of colistin for the treatment of multiresistant bacteria has led to the emergence of colistin-resistant strains of Gram-negative bacilli. Treatment of infections caused by these pan–drug-resistant bacteria is difficult owing to the paucity of effective antibiotics. We report two cases of ventilator-associated respiratory infection caused by pan–drug-resistant, colistin-resistant Pseudomonas aeruginosa that were successfully treated with ceftolozane-tazobactam.

AB - © 2017, Sociedad Espanola de Quiminoterapia. All rights reserved. The use of colistin for the treatment of multiresistant bacteria has led to the emergence of colistin-resistant strains of Gram-negative bacilli. Treatment of infections caused by these pan–drug-resistant bacteria is difficult owing to the paucity of effective antibiotics. We report two cases of ventilator-associated respiratory infection caused by pan–drug-resistant, colistin-resistant Pseudomonas aeruginosa that were successfully treated with ceftolozane-tazobactam.

KW - Ceftolozane-tazobactam

KW - Colistin-resistant pseudomonas aeruginosa

KW - ICU

KW - Ventilator-associated respiratory infection

M3 - Article

VL - 30

SP - 224

EP - 228

JO - Revista Espanola de Quimioterapia

JF - Revista Espanola de Quimioterapia

SN - 0214-3429

IS - 3

ER -